http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105950716-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-10 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105950716-B |
titleOfInvention | The application of miR-4443 and its target gene in diagnosis and treatment chondroblastic osteosarcoma |
abstract | The present invention relates to the application of miR 4443 and its target gene in diagnosis and treatment chondroblastic osteosarcoma.High-flux sequence is carried out to chondroblastic Patients with Osteosarcoma and normal healthy controls miRNA and mRNA, obtain it and express data, bioinformatic analysis chooses candidate gene, and then using the verification of RT PCR experiments and interference experiment verification target, the result shows that miR 4443 provided by the invention and its target gene and chondroblastic osteosarcoma are closely related, good Research foundation has been established for clinical diagnosis and prevention, there is good application prospect. |
priorityDate | 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 145.